Bausch Health Companies vs Universe Pharmaceuticals
Universe Pharmaceuticals is the larger business, with $17.86bn of revenue in fiscal 2025 against $10.27bn for Bausch Health Companies (1.7 times as much). Bausch Health Companies grew faster (6.7% against -22.4%). Bausch Health Companies kept more of each dollar of sales as profit: a net margin of 1.5% against -20.6%.
| Latest fiscal year | Bausch Health CompaniesBHC, 2025 | Universe PharmaceuticalsUPC, 2025 |
|---|---|---|
| Revenue | $10.27bn | $17.86bn |
| Revenue growth | 6.7% | -22.4% |
| Net income | $157m | −$3.67bn |
| Operating margin | 17.7% | -16.3% |
| Net margin | 1.5% | -20.6% |
| Return on equity | — | -7.2% |
| Free cash flow | $1.00bn | −$5.32bn |
| Cash | $1.31bn | $33.59bn |
| Total debt | $20.82bn | $9.26bn |
| Debt to equity | — | 16.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 20,300 | — |
| Market value | $3.01bn | $844,444 |
| Price vs our value range | Below our value range | — |
| Moat score | 35 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |